Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.

Henrich TJ, Hobbs KS, Hanhauser E, Scully E, Hogan LE, Robles YP, Leadabrand KS, Marty FM, Palmer CD, Jost S, Korner C, Li JZ, Ghandi RT, Hamdan A, Abramson J, LaCasce AS, Kuritzkes DR. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy. (2017) The Journal of infectious diseases. 216(2):254-262. [Article]